Cabot Corporation (NYSE:CBT) Given Consensus Rating of “Hold” by Analysts

Shares of Cabot Corporation (NYSE:CBTGet Free Report) have been given an average rating of “Hold” by the seven ratings firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $83.80.

A number of brokerages recently commented on CBT. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Truist Financial assumed coverage on Cabot in a report on Monday, June 8th. They issued a “buy” rating and a $98.00 price target on the stock. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. JPMorgan Chase & Co. increased their price target on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a report on Wednesday, May 13th. Finally, Mizuho increased their price target on Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th.

View Our Latest Research Report on CBT

Cabot Price Performance

Shares of Cabot stock opened at $87.49 on Wednesday. The stock has a 50 day moving average of $82.10 and a 200 day moving average of $75.22. Cabot has a 12 month low of $58.33 and a 12 month high of $93.15. The firm has a market cap of $4.52 billion, a PE ratio of 16.54, a PEG ratio of 11.93 and a beta of 0.82. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The company had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.31 million. During the same period in the prior year, the company earned $1.90 earnings per share. The firm’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, research analysts expect that Cabot will post 6.34 EPS for the current fiscal year.

Cabot Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 29th were issued a $0.4725 dividend. The ex-dividend date was Friday, May 29th. This is a positive change from Cabot’s previous quarterly dividend of $0.45. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. Cabot’s dividend payout ratio (DPR) is currently 35.73%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Public Employees Retirement System of Ohio grew its stake in Cabot by 15.4% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company’s stock worth $80,000 after purchasing an additional 160 shares in the last quarter. Janney Montgomery Scott LLC boosted its position in Cabot by 2.6% during the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company’s stock valued at $417,000 after acquiring an additional 161 shares in the last quarter. Farther Finance Advisors LLC boosted its position in Cabot by 9.6% during the 4th quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company’s stock valued at $124,000 after acquiring an additional 164 shares in the last quarter. Parallel Advisors LLC boosted its position in Cabot by 10.5% during the 1st quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company’s stock valued at $139,000 after acquiring an additional 175 shares in the last quarter. Finally, Gabelli Funds LLC boosted its position in Cabot by 1.3% during the 3rd quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company’s stock valued at $1,032,000 after acquiring an additional 180 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.

About Cabot

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.